Standard BioTools, headquartered in South San Francisco, offers biotechnology tools and services for clinical research, focusing on proteomics and genomics with 534 employees since its IPO in 2011. The company provides insights into health and disease using advanced technologies for diverse applications in translational and clinical research.
LAB has been in the news recently: Illumina, Inc. has agreed to acquire Standard BioTools' LAB subsidiary, SomaLogic. This acquisition is part of Illumina's strategy to enhance its capabilities in the biotechnology sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.